Section V. Dementias 26. The genetic landscape of Alzheimer
disease 27. Frontotemporal dementia 28. The genetics of dementia
with Lewy bodies 29. Prion disease
Section VI. Paroxysmal Disorders 30. Genetics of epilepsy 31.
Genetics of migraine 32. Periodic paralysis 33. Episodic ataxias
34. Disorders of sleep and circadian rhythms
Section VII. Neuromuscular Disorders 35. Facioscapulohumeral
muscular dystrophy 36. The genetics of congenital myopathies 37.
Genetic basis and phenotypic features of congenital myasthenic
syndromes 38. Spinal muscular atrophy 39. Emerging understanding of
the genotype: Phenotype relationship in amyotrophic lateral
sclerosis 40. Spinal and bulbar muscular atrophy 41. Hereditary
spastic paraplegia 42. Neuropathy
Section VIII. Diseases of White Matter and Demyelination 43.
The spectrum of adult-onset heritable white matter disorders 44.
Alexander disease 45. Neurogenetics of Pelizaeus-Merzbacher disease
46. Multiple sclerosis
Section IX. Cerebrovascular Diseases 47. CADASIL
Section X. Major Adult Psychiatric Disorders 48.
Neuroepigenetics and addiction 49. Genetic susceptibility in
obsessive-compulsive disorder
Section XI. Cancer and Phakomatoses 50. Brain cancer genomics
and epigenomics 51. Neurofibromatosis type 1 52. Tuberous sclerosis
complex 53. Von Hippel-Lindau disease and Sturge-Weber syndrome
Dr. Geschwind is the Gordon and Virginia MacDonald Distinguished
Professor of Human Genetics, Neurology and Psychiatry at UCLA. In
his capacity as Senior Associate Dean and Associate Vice Chancellor
of Precision Health, he leads the Institute for Precision Health at
UCLA. His laboratory has pioneered the application of systems
biology methods in neurologic and psychiatric disease, describing
multiple disease-causing genes and disease mechanisms in the book
“Neurodevelopmental and Neurodegenerative Diseases. Dr. Geschwind
has put considerable effort into fostering large-scale
collaborative patient resources for genetic research and data
sharing in autism research. He has served on numerous scientific
advisory boards, including the Faculty of 1000 Medicine, the
Executive Committee of the American Neurological Association, the
Scientific Advisory Board for the Allen Institute for Brain
Science, the NIMH Advisory Council and the NIH Council of Councils.
He has published over 400 papers and serves on the editorial boards
of Cell, Neuron and Science. He has received several awards for his
laboratory’s work and leadership including the Ruane Prize from the
Brain and Behavior Foundation in 2013 and the Derek Denny-Brown
Neurological Scholar Award from the American Neurological
Association (ANA) in 2004. He is an elected Member of the American
Association of Physicians and the National Academy of Medicine. Dr.
Henry Paulson is the Lucile Groff Professor of Neurology for
Alzheimer’s Disease and Related Disorders in the Department of
Neurology at the University of Michigan. Dr. Paulson joined the U-M
faculty in 2007, where he directs the programs in neurodegenerative
diseases, the Michigan Alzheimer’s Disease Center and co-directs
the University of Michigan Protein Folding Diseases Initiative. Dr.
Paulson received his MD and PhD from Yale University in 1990, then
completed a neurology residency and neurogenetics/movement
disorders fellowships at the University of Pennsylvania. From 1997
to 2007, he was on the Neurology faculty at the University of Iowa.
Dr. Paulson’s research and clinical interests concern the causes
and treatment of age-related neurodegenerative diseases, with a
focus on hereditary ataxias, polyglutamine diseases, and
frontotemporal dementia. Dr. Paulson serves on the scientific
advisory boards of numerous disease-related national organizations,
and is past-Chair of the Board of Scientific Counselors at the
National Institute for Neurological Disorders and Stroke at the
National Institutes of Health. Dr. Christine Klein is a Professor
of Neurology and Neurogenetics. She studied medicine in Hamburg,
Heidelberg, Luebeck (1988-1994), and London (with Dr. N.P. Quinn in
1994/1995). She moved to Boston from 1997-1999 for a fellowship in
Molecular Neurogenetics under the mentorship of Dr. X.O.
Breakefield. Dr. Klein completed her neurology training at Luebeck
University with Dr. D. Koempf in 2004, followed by a series of
summer sabbaticals in movement disorders with Dr. A.E. Lang in
Toronto, Canada in 2004-2015. She was appointed Lichtenberg
Professor at the Department of Neurology of Luebeck University in
2005, where her research has focused on the clinical and molecular
genetics of movement disorders and its functional consequences. In
2009, Dr. Klein has been awarded a Schilling Section of Clinical
and Molecular Neurogenetics at the University of Luebeck and has
become Director of the newly founded Institute of Neurogenetics in
2013.
Dr. Klein has published over 400 scientific papers and is the 2008
recipient of the Derek Denny-Brown Award of the American
Neurological Association. She is an Associate Editor of ‘Annals of
Neurology’ and of ‘Movement Disorders’. She has served as chair of
the Congress Scientific Program Committee of the 2016/2017 Annual
Congresses of the International Parkinson and Movement Disorder
Society and is President-Elect of the German Neurological Society.
Ask a Question About this Product More... |